In today’s Pharma Pulse, Johnson & Johnson commits over $1 billion to a new biomanufacturing site in Pennsylvania, while Hims ...

A policy change allowing approval of some new drugs based on one adequate and well-controlled study could accelerate ...

Patients want pills. We see this in the GLP-1 space. Everything should actually be flowing money towards pills, because payers are also quicker to reward pills. Yet the money is going exactly in the ...

In today’s Pharma Pulse, HHS Secretary RFK Jr. centralizes department operations under CMS leadership, while a new telehealth model shows a 66% reduction in repeat ER visits for older adults.

Turning to market access, Eli Lilly has entered a $100 million licensing agreement with CSL Limited for clazakizumab. While CSL maintains the rights for kidney-related cardiovascular trials, Lilly ...

In the final part of his Pharma Commerce video interview, Dan Chancellor, Norstella’s vice president of thought leadership, shares that companies facing the largest revenue gaps from looming patent ...

In the first part of his Pharma Commerce video interview, John Stanford, Incubate’s executive director, explains how third round of CMS drug selections brings physician-administered medicines under ...

DHL Group—capitalizing off the momentum garnered from the LAX cold storage project —is expanding its dedicated airfreight cold chain network, aimed at strengthening global logistics for ...

PC: Tecsys’ new survey shows that only 20% of healthcare leaders report having real-time visibility across pharmacy inventory ...

This eBook highlights Werner’s premium and expedited shipping solutions designed specifically to address the high-stakes requirements of the $1.6 trillion global pharmaceutical industry. It details ...